ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000258450.1	ABT-263 (navitoclax)	Colon adenocarcinoma	0.041676934	Sensitive
ENSG00000258450.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.040163038	Sensitive